Enzo Biochem
ENZ
$1.39
Share price
-0.71%
Change (1 day)
-44.62%
Change (1 year)
Categories
Enzo Biochem (ENZ) - Total debt
Total debt on the balance sheet as of April 2023 : $21.91 M
According to Enzo Biochem's latest financial reports the company's total debt is $21.91 M. A company’s total debt is the sum of all current and non-current debts.
Enzo Biochem - Total debt on balance sheet (from 2005 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-07-31 | $20.58 M | -9.21% |
| 2021-07-31 | $22.67 M | -30.84% |
| 2020-07-31 | $32.79 M | 612.36% |
| 2019-07-31 | $4.6 M | 1203.97% |
| 2018-07-31 | $0.35 M | -38.39% |
| 2017-07-31 | $0.57 M | -76.67% |
| 2016-07-31 | $2.45 M | -31.51% |
| 2015-07-31 | $3.58 M | -12.88% |
| 2014-07-31 | $4.11 M | -5.79% |
| 2013-07-31 | $4.36 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Quest Diagnostics
DGX | $4.95 B | 22,524.21% | 🇺🇸 USA |
 LabCorp LH | $6.21 B | 28,232.95% | 🇺🇸 USA |
 RadNet RDNT | $1.55 B | 6,983.67% | 🇺🇸 USA |
 Psychemedics PMD | $2.98 M | -86.38% | 🇺🇸 USA |
 NeoGenomics
NEO | $0.60 B | 2,681.09% | 🇺🇸 USA |
 Qiagen QGEN | $1.88 B | 8,513.94% | 🇳🇱 Netherlands |